Cyclosporine-A

DRUG2 trials

Sponsors

Tehran University of Medical Sciences, Memorial Sloan Kettering Cancer Center

Conditions

ALLAMLAutoimmune HepatitisBone Marrow FailureHLHHemoglobinopathiesInherited Metabolic DisordersMDS

Phase 2

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

RecruitingNCT04644016

Memorial Sloan Kettering Cancer CenterALL, AML, Bone Marrow Failure +6

Start: 2020-11-20End: 2026-12-20Target: 31Updated: 2026-03-13

Phase 3

Cyclosporine-A Versus Prednisolone for Induction of Remission in Auto-immune Hepatitis

CompletedNCT01170351

Tehran University of Medical SciencesAutoimmune Hepatitis

Start: 2005-12-31End: 2018-12-31Updated: 2019-07-19